公司资料
Homology Medicines 股价、新闻与催化剂
- 股票代码:
- FIXX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
11.90 USD (-1.68%)
收盘价
最后更新: 2026年9月17日
—
市值
股价为何变动
截至 2026年9月17日，FIXX 下跌 1.68%，收于 $11.90。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Homology Medicines was a gene-therapy company focused on genetic medicine before its restructuring and wind-down. Its platform centered on AAV-based delivery and genome repair.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Homology sat in gene therapy.
商业模式特征
The company depended on platform validation, clinical data, and the challenge of turning gene therapy into durable value.
生物医药行业定位
Homology belongs to the historical gene-therapy category rather than the current live public-company set.
未来催化剂
- Homology’s catalysts are gene-editing and ex vivo platform updates, plus any strategic step that shows the company still has a viable path. The market will care about whether the platform can still generate value.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。